American Cannabis Stock Performance
| AMMJ Stock | USD 0.0002 0.0003 60.00% |
American Cannabis holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -10.09, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning American Cannabis are expected to decrease by larger amounts. On the other hand, during market turmoil, American Cannabis is expected to outperform it. Use American Cannabis potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to analyze future returns on American Cannabis.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in American Cannabis are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent primary indicators, American Cannabis revealed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.7 M | |
| Total Cashflows From Investing Activities | -1.5 M |
American |
American Cannabis Relative Risk vs. Return Landscape
If you would invest 0.50 in American Cannabis on August 25, 2024 and sell it today you would lose (0.48) from holding American Cannabis or give up 96.0% of portfolio value over 90 days. American Cannabis is currently generating 7.6342% in daily expected returns and assumes 61.2027% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than American, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
American Cannabis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for American Cannabis' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as American Cannabis, and traders can use it to determine the average amount a American Cannabis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1247
| Best Portfolio | Best Equity | AMMJ | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 61.2 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average American Cannabis is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of American Cannabis by adding it to a well-diversified portfolio.
American Cannabis Fundamentals Growth
American Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of American Cannabis, and American Cannabis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on American Pink Sheet performance.
| Return On Equity | -0.93 | |||
| Return On Asset | -0.23 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.49 M | |||
| Shares Outstanding | 85.73 M | |||
| Price To Earning | 62.93 X | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 2.43 M | |||
| EBITDA | (1.27 M) | |||
| Cash And Equivalents | 873.76 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 806.73 K | |||
| Debt To Equity | 0.49 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (957.92 K) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 4.22 M | |||
| Retained Earnings | (4.5 M) | |||
| Current Asset | 379 K | |||
| Current Liabilities | 541 K | |||
About American Cannabis Performance
By evaluating American Cannabis' fundamental ratios, stakeholders can gain valuable insights into American Cannabis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if American Cannabis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if American Cannabis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
American Cannabis Company, Inc., together with its subsidiary, Hollister Blacksmith, Inc., provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. American Cannabis Company, Inc. was founded in 2013 and is headquartered in Denver, Colorado. American Cannabis operates under Consulting Services classification in the United States and is traded on OTC Exchange. It employs 7 people.Things to note about American Cannabis performance evaluation
Checking the ongoing alerts about American Cannabis for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for American Cannabis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| American Cannabis is way too risky over 90 days horizon | |
| American Cannabis has some characteristics of a very speculative penny stock | |
| American Cannabis appears to be risky and price may revert if volatility continues | |
| American Cannabis has high likelihood to experience some financial distress in the next 2 years | |
| American Cannabis currently holds 806.73 K in liabilities with Debt to Equity (D/E) ratio of 0.49, which is about average as compared to similar companies. American Cannabis has a current ratio of 0.47, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist American Cannabis until it has trouble settling it off, either with new capital or with free cash flow. So, American Cannabis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like American Cannabis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for American to invest in growth at high rates of return. When we think about American Cannabis' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.43 M. Net Loss for the year was (1.44 M) with profit before overhead, payroll, taxes, and interest of 1.06 M. | |
| American Cannabis currently holds about 873.76 K in cash with (957.92 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 25.0% of American Cannabis shares are held by company insiders |
- Analyzing American Cannabis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether American Cannabis' stock is overvalued or undervalued compared to its peers.
- Examining American Cannabis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating American Cannabis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of American Cannabis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of American Cannabis' pink sheet. These opinions can provide insight into American Cannabis' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in American Pink Sheet
American Cannabis financial ratios help investors to determine whether American Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Cannabis security.